Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan.


Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
04 03 2021
Historique:
received: 12 10 2020
accepted: 11 02 2021
entrez: 5 3 2021
pubmed: 6 3 2021
medline: 26 11 2021
Statut: epublish

Résumé

Higher smoking prevalence in people with serious psychological distress (SPD) is well-recognized. However, gender and age differences in the association between heaviness of cigarette smoking and SPD have not been fully investigated. We used anonymized data from a nationally representative survey in Japan (33,925 men and 37,257 women). SPD was measured using the Kessler 6-item Psychological Distress Scale and defined as ≥ 13 points. Multiple logistic regression analyses stratified by gender and age-groups (20-44 years, 45-64 years, and ≥ 65 years) were used to estimate adjusted odds ratio (aOR) and 95% confidence interval (CI) for SPD. After adjusting for sociodemographic confounders including education, equivalent household expenditures, and employment contract, women had a significant association between heavier smoking and more frequent SPD: compared to never-smokers, aORs (95% CIs) of ex-smokers, current light smokers who smoked 1-10 cigarettes per day (CPD), current moderate smokers 11-20 CPD, and current heavy smokers ≥ 21 CPD were 1.22 (0.92-1.63), 1.52 (1.25-1.84), 1.75 (1.46-2.09), and 2.22 (1.59-3.10), respectively (P-trend < 0.001). A significant positive association among women was consistent across all age-groups. Among men, there was no association between heaviness of cigarette smoking and SPD in all age-groups, and only current heavy smokers aged 20-44 years had a significantly higher OR for SPD (aOR, 1.37 [95% CI, 1.02-1.85]) than never-smokers. There was a positive association between heaviness of cigarette smoking and SPD only among women, but not among men. For female smokers experiencing mental disorders, there is a need not only to improve mental health services but also to improve smoking-cessation support.

Sections du résumé

BACKGROUND
Higher smoking prevalence in people with serious psychological distress (SPD) is well-recognized. However, gender and age differences in the association between heaviness of cigarette smoking and SPD have not been fully investigated.
METHODS
We used anonymized data from a nationally representative survey in Japan (33,925 men and 37,257 women). SPD was measured using the Kessler 6-item Psychological Distress Scale and defined as ≥ 13 points. Multiple logistic regression analyses stratified by gender and age-groups (20-44 years, 45-64 years, and ≥ 65 years) were used to estimate adjusted odds ratio (aOR) and 95% confidence interval (CI) for SPD.
RESULTS
After adjusting for sociodemographic confounders including education, equivalent household expenditures, and employment contract, women had a significant association between heavier smoking and more frequent SPD: compared to never-smokers, aORs (95% CIs) of ex-smokers, current light smokers who smoked 1-10 cigarettes per day (CPD), current moderate smokers 11-20 CPD, and current heavy smokers ≥ 21 CPD were 1.22 (0.92-1.63), 1.52 (1.25-1.84), 1.75 (1.46-2.09), and 2.22 (1.59-3.10), respectively (P-trend < 0.001). A significant positive association among women was consistent across all age-groups. Among men, there was no association between heaviness of cigarette smoking and SPD in all age-groups, and only current heavy smokers aged 20-44 years had a significantly higher OR for SPD (aOR, 1.37 [95% CI, 1.02-1.85]) than never-smokers.
CONCLUSIONS
There was a positive association between heaviness of cigarette smoking and SPD only among women, but not among men. For female smokers experiencing mental disorders, there is a need not only to improve mental health services but also to improve smoking-cessation support.

Identifiants

pubmed: 33663543
doi: 10.1186/s12954-021-00469-5
pii: 10.1186/s12954-021-00469-5
pmc: PMC7931554
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27

Références

J Epidemiol. 2009;19(6):294-302
pubmed: 19749498
Nicotine Tob Res. 2011 Dec;13(12):1183-92
pubmed: 21849411
Nicotine Tob Res. 2011 Dec;13(12):1167-75
pubmed: 22071378
J Affect Disord. 2011 Nov;134(1-3):160-7
pubmed: 21665286
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Eur J Public Health. 2015 Apr;25(2):231-6
pubmed: 25172836
J Appl Res Intellect Disabil. 2018 May;31(3):343-359
pubmed: 29124850
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
Nicotine Tob Res. 2018 May 3;20(6):707-713
pubmed: 28482108
Psychopharmacology (Berl). 2005 Aug;181(1):107-17
pubmed: 15834539
Am J Prev Med. 2019 Aug;57(2):262-272
pubmed: 31326010
Pharmacol Biochem Behav. 2002 Jun;72(3):707-16
pubmed: 12175468
J Occup Health. 2010;52(4):227-40
pubmed: 20526043
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795
Keio J Med. 2001 Dec;50(4):263-8
pubmed: 11806504
Biol Psychol. 2011 Sep;88(1):1-12
pubmed: 21741435
Nord J Psychiatry. 2018 Sep;72(sup1):S20-S22
pubmed: 30489215
Public Health. 2019 Jun;171:116-122
pubmed: 31125867
Addict Behav. 2008 Apr;33(4):582-92
pubmed: 18158218
Psychoneuroendocrinology. 2008 Jun;33(5):560-8
pubmed: 18321653
Prev Med Rep. 2019 Aug 30;16:100983
pubmed: 31516816
Ann Epidemiol. 2005 May;15(5):365-72
pubmed: 15840550
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
PLoS One. 2018 Feb 6;13(2):e0192451
pubmed: 29408939
Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1261-71
pubmed: 23272325
Adv Data. 2007 Mar 30;(382):1-18
pubmed: 17432488
J Epidemiol. 2020 Mar 5;30(3):136-142
pubmed: 30828035
J Anxiety Disord. 2018 Aug;58:78-106
pubmed: 30075356
Am J Health Behav. 2014 Jul;38(4):570-6
pubmed: 24636119
PLoS One. 2019 Mar 13;14(3):e0212765
pubmed: 30865656
Int J Public Health. 2009 Jun;54 Suppl 1:68-74
pubmed: 19396580
Psychol Med. 2012 Jun;42(6):1273-82
pubmed: 22011372
Nicotine Tob Res. 2017 Jan;19(1):3-13
pubmed: 27199385
PLoS One. 2019 Nov 14;14(11):e0224821
pubmed: 31725817
J Affect Disord. 2018 Oct 15;239:131-137
pubmed: 30005326
Arch Gen Psychiatry. 2009 Jul;66(7):785-95
pubmed: 19581570
Aust N Z J Psychiatry. 2011 Feb;45(2):170-8
pubmed: 21080851
Nicotine Tob Res. 2015 Apr;17(4):463-72
pubmed: 25762757

Auteurs

Kimiko Tomioka (K)

Nara Prefectural Health Research Center, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. tkimiko@naramed-u.ac.jp.

Midori Shima (M)

Nara Prefectural Health Research Center, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.

Keigo Saeki (K)

Nara Prefectural Health Research Center, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH